Then, after acquiring oncogenes and tumor suppressor mutations, TGFβ becomes pro-tumoral by promoting the production of ECM components via tumor-associated fibroblasts (CAFs) [42,44], angiogenesis and EMT induction [44]. The gene discussed is TGFB1; the disease is neoplasm.